ARCHIVES

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

This article is from The Cancer Letter archive.

Vol. 19 No. 24 | June 11, 1993

Download PDF Visit The Full Archive

Related Articles

NCI Stands Firm On Assist “Downscaling” Despite 150 Letters From States, Volunteers

January 15, 1993

Risks Of Long-Term HRT Outweigh Benefits, WHI Finds

March 28, 2008

NCI Information Officer Plays Key Role In Cancer Program

February 8, 1980

More DCT Concepts Approved By Advisors

July 10, 1992

Minnesota Study Aimed At Finding Final Answer On Hemoccult Screening

July 24, 1987

CALGB Grant OKed, But Group May Lose Support For Its Non-Hematologic Segments

January 8, 1982